Alexandra Clipson
Cancer Research UK Manchester Institute(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Viral-associated cancers and disorders, RNA modifications and cancer
Most-Cited Works
- → Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study(2019)304 cited
- → Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial(2019)261 cited
- → KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype(2014)176 cited
- → cfDNA methylome profiling for detection and subtyping of small cell lung cancers(2022)136 cited
- → Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit(2019)116 cited
- → A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer(2022)108 cited
- → Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cell(2019)83 cited
- → Nucleolar Targeting of RelA(p65) Is Regulated by COMMD1-Dependent Ubiquitination(2010)69 cited
- → Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors(2017)67 cited
- → Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma(2025)63 cited